fpo-home-page

Partners Online Second Opinions

For those with complex medical questions or concerns, looking for answers or alternatives, or simply peace of mind – we are here to help.

Partners Online Second Opinions has provided thousands of patients and physicians remote access to the many specialists affiliated with Partners HealthCare, a Harvard Medical School-affiliated healthcare delivery system, based in Boston, Massachusetts.

The Partners HealthCare network includes top hospitals in the United States, including Massachusetts General Hospital, Brigham and Women’s Hospital, Dana Farber Cancer Institute, and Spaulding Rehabilitation Hospital. Many of our specialists are world-renowned experts in their field, and are available to review medical history and related materials, and provide you with a written consultation report.

When you are faced with decisions regarding a new diagnosis or treatment plan, having another expert opinion is the first step towards getting the care you need.

For 200 years, patients have been traveling to Boston to get some of the best care in the world. Now you can access this expertise from the comfort of your home.


Featured Specialist
fpo-callout-home

Robert Haddad, MD


Robert I. Haddad, MD, is Assistant Professor of Medicine, Harvard Medical School, Boston, Massachusetts. He is Clinical Director/Head and Neck Oncology Program, and a member of the Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Dr. Haddad received his medical degree from Saint Joseph University, French Faculty of Medicine, Beirut, Lebanon, and served as intern and resident at St. Luke’s Roosevelt Hospital Center, New York, New York. He served a fellowship in hematology/oncology at Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland. Dr. Haddad’s current research activity involves the use of intensive chemoradiotherapy regimens for patients with locally advanced head and neck cancer with particular attention to radioprotection. He is also involved in a large phase III study comparing sequential chemoradiotherapy to concomitant chemoradiotherapy: The Paradigm Trial. Dr. Haddad lectures extensively on head and neck cancer, both on the regional and the national level.

Read More